Can a blood test reveal when breast cancer treatment stops working?
Knowledge-focused
Recruiting now
Researchers are studying whether blood and tissue samples can show when metastatic breast cancer stops responding to standard first-line treatment with an aromatase inhibitor and a CDK4/6 inhibitor. The study enrolls women with ER-positive, HER2-negative metastatic breast cancer …
Sponsor: Fondazione Sandro Pitigliani • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC